Stay updated with breaking news from Nasdaq Cyth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright assumed coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $3.00 target price on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 […]
HC Wainwright began coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating and a $3.00 price target on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 earnings at […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 45,600 shares, a decrease of 59.5% from the March 15th total of 112,600 shares. Approximately 0.4% of the shares of the company are […]
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Profitability This table compares Cyclo Therapeutics and Revolution […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report)’s stock price fell 1.1% during mid-day trading on Friday . The stock traded as low as $1.81 and last traded at $1.88. 26,821 shares changed hands during trading, a decline of 76% from the average session volume of 111,431 shares. The stock had previously closed at $1.90. […]